Status: Recruiting
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults
The main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of study interventions across intervention groups
Participants needed: 375
Trial details
Phase: Phase 1Age: 60+Biological sex: AllType: InterventionalSponsor: ModernaTX, Inc.Updated: Aug 19, 2026Locations: 10
Eligibility criteria
In good general health or with stable chronic medical conditions, as determined... [+1]
History of anaphylaxis or severe hypersensitivity reaction requiring medical int... [+5]